Cite

HARVARD Citation

    Li, Z. et al. (2020). The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma. Cell cycle. 19 (21), pp. 2918-2926. [Online]. 
  
Back to record